Histamine as an autocrine growth factor: An unusual role for a widespread mediator

Seminars in Cancer Biology

Volumn 10, Issue 1, 2000, Pages 15-23

  Rivera, Elena S ^a   Cricco, Graciela P ^a   Engel, Nora I ^a   Fitzsimons, Carlos P ^a   Martín, Gabriela A ^a   Bergoc, Rosa M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Growth factors; Histamine; Histamine receptors; Histidine decarboxylase (HDC); NMU induced carcinomas

Indexed keywords

ASTEMIZOLE; CALMODULIN; ESTRADIOL; ESTROGEN; GASTRIN; GLUCOCORTICOID; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTIDINE DECARBOXYLASE; RANITIDINE; TESTOSTERONE;

ANIMAL MODEL; AUTOCRINE EFFECT; BREAST CARCINOMA; CANCER GROWTH; CELL PROLIFERATION; ENZYME SYNTHESIS; HISTAMINE RELEASE; NONHUMAN; REVIEW; TUMOR CELL LINE;

EID: 0034081863     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.2000.0303     Document Type: Article

References (70)

1. Kahlson G, Rosengren E. New approaches to the physiology of histamine. Physiol Rev. 48:1968;155-196.
2. Bartholeyns J, Fozard J. Role of histamine in tumor development. Trends Pharmacol Sci. 6:1985;123-125.
3. Metcalfe D, Baram D, Mekori J. Mast cells. Physiol Rev. 77:1997;1033-1079.
4. Falus A, Merety K. Histamine: an early messenger in inflammatory and immune reactions. Immunol Today. 13:1992;154-156.
5. Nielsen H J. Histamine-2 receptor antagonists as immunomodulators: New therapeutic views? Ann Med. 28:1996;107-113.
6. Leurs R, Smit M J, Timmerman H. Molecular pharmacological aspects of histamine receptors. Pharmacol Ther. 66:1995;413-463.
7. Garcia-Caballero M, Neugebauer E, Rodriguez F, Nuñez de Castro I, Heredia A, Oosting E, Vara Thorbeck C. Changes in histamine synthesis, tissue content and catabolism in human breast cancer. Agents Actions. 27:1989;227-231.
8. Bartholeyns J, Bouclier M. Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase. Cancer Res. 44:1984;639-645.
9. Mitsuhashi M, Payan D G. Functional diversity of histamine and histamine receptors. J Invest Dermatol. 98:1992;8S-11S.
10. Rivera E, Melito G, Davio C, Cricco G, Martin G, Mohamad N, Andrade N, Caro R, Bergoc R M. Histopathology and influence of the estral cycle on NMU-induced tumors in rats. Cancer Lett. 86:1994;223-228.
11. Martín G, Rivera E, Davio C, Melito G, Levin E, Cricco G, Andrade N, Caro R, Bergoc R M. Receptor characterization of intraperitoneal NMU-induced mammary tumors in rats. Cancer Lett. 101:1996;1-8.
12. 1receptor: II. Stable expression in chinese hamster ovary cells reveals the interaction with three major signal transduction pathways. J Neurochem. 62:1994;519-527.
13. 2+] i signaling systems. Am J Physiol. 263:1992;G967-G972.
14. 2receptor biology. Am J Phisiol. 273:1997;G987-G996.
15. Davio C, Mladovan A, Shayo C, Lemos B, Baldi A, Rivera E. Histamine receptors in neoplastic transformation: Studies in human cell lines. Inflamm Res. 45:1996;S62-S63.
16. 2histamine receptors with signal transduction pathways during multistage mouse skin carcinogenesis. Inflamm Res. 46:1997;292-298.
17. Seuwem K, Pouyssegur J. G-protein-controlled signal transduction pathways and the regulation of cell proliferation. Adv Cancer Res. 58:1992;75-94.
18. Fitzsimons C, Durán H, Labombarda F, Molinari B, Rivera E. Histamine receptors signalling in epidermal tumor cell lines with H-ras gene alterations. Inflamm Res. 47:1998;S50-S51.
19. Zhu X, Gilbert S, Birnbaumer M, Birnbaumer L. Dual signaling potential is common among Gs coupled receptors and dependent on receptor density. Mol Pharmacol. 46:1994;460-469.
20. 2receptor: desensitizing and sensitizing effects of histamine stimulation on histamine-dependent cAMP production in chinese hamster ovary cells. Biochem J. 320:1996;27-32.
21. 3receptor. Mol Pharmacol. 55:1999;1101-1107.
22. Post G R, Brown J H. G-protein coupled receptors and signalling pathways regulating growth responses. FASEB J. 10:1996;741-749.
23. 1histamine receptor signaling in Balb/3T3 cells transformed by v-K-ras and v-H-ras oncogenes. Oncogene. 7:1992;2053-2057.
24. 1receptors. J Cell Biol. 11:1990;1211-1215.
25. Lemos B, Davio C, Gass H, Gonzalez P, Cricco G, Martin G, Bergoc R, Rivera E. Histamine receptors in human mammary gland, different benign lesions and mammary carcinomas. Inflamm Res. 44:1995;68-69.
26. 2receptor is linked to cell proliferation and c-fos gene transcription. Am J Physiol. 273:1997;C2037-2045.
27. 2receptor activity during the differentiation of human monocytic-like cell line U937. FEBS Lett. 184:1985;207-213.
28. 2receptor on the human monocytic cell line U937. Mol Pharmacol. 51:1997;983-990.
29. 2histamine receptors in experimental carcinomas with an atypical coupling to signal transducers. Biochem Pharmacol. 50:1995;91-96.
30. Rivera E, Davio C, Venturino A, Caro R A, Bergoc R M. Histamine receptors in an experimental mammary carcinoma. Biomed Pharmacother. 48:1994;399-406.
31. Cricco G, Davio C, Bergoc R M, Rivera E. Inhibition of tumor growth induced by histamine in vivo and in vitro studies. Agents Actions. 38:1993;75-78.
32. 2receptors. Garcia-Caballero M, Brandes L, Hosoda S. Histamine in normal and cancer cell proliferation, Advances in the Bioscience. 1993;299-317 Pergamon Press, Oxford.
33. Davio C, Martin G, Cricco G, Fitzsimons C, Bergoc R, Rivera E. Role of histamine on growth and differentiation of the rat mammary gland. Agents Actions. 41:1994;115-117.
34. Moolenar W H. G-protein coupled receptors, phosphoinositide hydrolysis and cell proliferation. Growth Differ. 2:1991;359-354.
35. Medina M A, Rodriguez Quesada A, Nuñez de Castro I, Sánchez-Jimenez F. Histamine, polyamines and cancer. Biochem Pharmacol. 57:1999;1341-1344.
36. Hayashi H, Watanabe T. Histamine and its related enzymes. Parvez S H, Naoi M, Nagatsu S, Parvez S. Methods in Neurotransmitter and Neuropeptide Research. 1993;111-119 Elsevier Science Publishers.
37. Huzsti Z, Magyar K, Keleti J. Possible regulation of hypothalamus and lung histidine decarboxylase activity by cAMP-dependent protein. Eur J Biol. 197:1991;191-196.
38. Zahnow C, Panula P, Yamatodani A, Millhorn D. Glucocorticoid hormones downregulate histidine decarboxylase mRNA and enzyme activity in rat lung. Am J Physiol. 275:1998;L407-L413.
39. Middleton R J, Martin S A, Bulfield G. A new regulatory gene in the histidine decarboxylase gene complex determines the responsiveness of the mouse kidney enzyme to testosterone. Genet Res. 49:1987;61-67.
40. Hocker M, Zhengsheng Z, Fenstermacher D A, Tagerud S, Chulak M, Joseph D R, Wang T C. Rat histidine decarboxylase promoter is regulated by gastrin through a protein kinase C pathway. Am J Physiol Gastroint & Liver Physiol. 33:1996;4-7.
41. Joseph D R, Sullivan P M, Wang Y M, Kozak C, Fenstermacher D A, Behrendsen M E, Zahnow C A. Characterization and expression of the complementary DNA encoding rat histidine decarboxylase. Proc Natl Acad Sci USA. 87:1990;733-737.
42. Engel N, Cricco G, Davio C, Martin G, Croci M, Fitzsimons C, Bergoc R, Rivera E. Histamine regulates the expression of histidine decarboxylase in NMU-induced tumors in rats. Inflamm Res. 45:1996;64-65.
43. Kierska D, Fogel W, Maslinski C. Histamine concentration and metabolism in mouse mammary gland during estrous cycle. Inflamm Res. 46:1997;63-64.
44. Schad J, Snass D. Histamine and DNA synthesis as age related and strain-related factors during rat mammary carcinogenesis. J Natl Cancer Inst. 65:1980;949-953.
45. Scolnik A, Bergoc R M, Rivera E, Venturino A, Comolli R, Rubio M, Caro R. Histamine metabolism in experimental mammary carcinomas. Acta Bioq Clínica Latinoamer. 20:1986;469-477.
46. Martín G, Davio C, Rivera E, Melito G, Cricco G, Andrade N, Caro R, Bergoc R M. Hormone dependence of mammary tumors induced in rat by intraperitoneal NMU injection. Cancer Invest. 1:1997;8-17.
47. Martín G, Cricco G, Engel N, Cocca C, Rivera E, Bergoc R. Epidermal growth factor in NMU-induced mammary tumors in rats. Breast Cancer Res Treat. 48:1998;175-185.
48. Falus A. Histamine release: cellular sources of histamine. Histamine and Inflammation. 1994;RG Landes Company, Austin. p. 33-60.
49. Dy M, Schneider E, Piquet-Pellorce C. A new role for endogenous histamine during hematopoiesis. Garcia-Caballero M, Brandes L, Hosoda S. Histamine in Normal and Cancer Cell Proliferation. Advances in the Bioscience. 1993;117-135 Pergamon Press, Oxford.
50. Bayliss D A, Wang Y, Zahnow C A, Joseph D R, Millhorn D E. Localization of histidine decarboxylase mRNA in rat brain. Mol Cell Neurosci. 1:1990;3-9.
51. Merickel A, Edwards H. Transport of histamine by vesicular monoamine transproter-2. Neuropharmacology. 34:1995;1543-1547.
52. Falus A, Kászlo V, Radvány Z, Hegyesi H, Kiss B, Bencsáth M, Darvas Z. Histidine decarboxylase and intracellular histamine in melanoma cells and in a T cell line. Inflamm Res. 46:1997;S51-S52.
53. Reynolds J L, Akhter J, Adams W J, Morris D L. Histamine content in colorectal cancer. Are there sufficient levels of histamine to affect lymphocyte function? Eur J Surg Oncol. 23:1997;224-227.
54. G, Cricco, G, Martin, F, Labombarda, C, Cocca, R, Bergoc, E, Rivera, Human pancreatic carcinoma cell line Panc-1 and the role of histamine in cell growth, Inflamm Res (in press).
55. 2receptor antagonist on cellular proliferation of human malignant melanoma cell lines. Melanoma Res. 6:1996;95-99.
56. 2receptor antagonists on melanogenesis and cellular proliferation in melanoma cells in culture. Biochem Biophys Res Commun. 177:1990;545-550.
57. Hirohata M, Sasaguri Y, Shigemori M, Maruiwa H, Morimatsu M. A role of histamine in human malignant glioma cells. Int J Oncol. 7:1995;1109-1115.
58. Van der Ven L TM, Prinsen I M, Jansen G H, Roholl P JM, Defferrari R, Slater R, Den Otter W. Growth of cultured human glioma tumour cells can be regulated with histamine and histamine antagonists. Br J Cancer. 68:1993;475-483.
59. Lawson J A, Adams W J, Morris D L. Ranitidine and cimetidine differ in their in vitro and in vivo effects on human colonic cancer growth. Br J Cancer. 73:1996;872-876.
60. 2receptors on human melanoma cells. Biochem Biophys Res Commun. 151:1988;518-523.
61. Takashi N, Mitsunobu M, Masaki D, Kenji T. Histamine-induced differentiation of HL-60 cells. Biochem Pharmacol. 6:1992;1115-1121.
62. Batra S, Fadeel I. Release of intracellular calcium and stimulation of cell growth by ATP and histamine in human ovarian cancer cells (SKOV-3). Cancer Lett. 77:1994;57-63.
63. 2histamine receptors in histiocytic lymphoma cell line U-937. Inflamm Res. 44:1995;S72-73.
64. Yamauchi K, Mamure-Sato R, Tanno Y, Ohtsa H, Takishima T, Shibahara S, Maeyama K, Watanabe T. Molecular biological aspects of human L-histidine decarboxylase. García-Caballero M, Brandes L, Hosoda S. Histamine in Normal Cancer Cell Proliferation, Advances in the Bioscience. 1993;177-196 Pergamon Press, Oxford.
65. 2receptor-mediated adenylate cyclase activation in the human gastric cancer cell line HGT-1. FEBS Lett. 177:1984;227-230.
66. 2-receptors on human carcinoma gastric cell line MKN-45 and their increase by retinoid acid treatment. Biochem Biophys Res Commun. 176:1991;1027-1032.
67. Cricco G, Davio C, Fitzsimons C, Engel N, Bergoc R, Rivera E. Histamine as an autocrine growth factor in experimental carcinomas. Agents Actions. 43:1994;17-20.
68. Cricco G, Engel N, Croci M, Davio C, Martin G, Fitzsimons C, Bergoc R, Rivera E. Fluoromethylhistidine inhibits tumor growth without producing depletion of endogenous histamine. Inflamm Res. 46:1997;59-61.
69. 2-antagonists as potential adjuvant treatment of malignant disease. Garcia-Caballero M, Brandes L, Hosoda S. Histamine in Normal and Cancer Cell Proliferation, Advances in the Bioscience. 1993;319-334 Pergamon Press, Oxford.
70. 2-antihistaminics (ranitidine or cimetidine). Eur J Cancer Clin Oncol. 24:1988;161-167.